• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优化局部用药品生物等效性评估的指标

Optimizing metrics for the assessment of bioequivalence between topical drug products.

作者信息

N'Dri-Stempfer Berthe, Navidi William C, Guy Richard H, Bunge Annette L

机构信息

Chemical Engineering Department, Colorado School of Mines, 1500 Illinois Street, Golden, Colorado 80401, USA.

出版信息

Pharm Res. 2008 Jul;25(7):1621-30. doi: 10.1007/s11095-008-9577-4. Epub 2008 May 1.

DOI:10.1007/s11095-008-9577-4
PMID:18449629
Abstract

PURPOSE

Stratum corneum tape stripping post-application of a drug product followed by analysis of the active agent in this tissue layer is an approach being seriously considered for the comparative assessment of topical bioavailability. Key issues revolve around how best to perform this experiment and interpret the data.

METHODS

Using previously published results from a comparative study of three 0.025% tretinoin gel products, alternative data analysis approaches are presented that may render the technique more accessible to the evaluation of new and generic topical dosage forms.

RESULTS

For the tretinoin gel study, the conclusions for bioequivalence from measurements of drug levels at only one uptake and one clearance time were the same as those from the original study, which required measurements at eight different treatment times. Furthermore, comparisons of drug levels at one uptake and one clearance time discriminated differences in bioequivalence for clearance and uptake, which had previously been missed. Half-life estimates, derived from time course data of drug clearance, can be related to lag time for drug penetration through the SC.

CONCLUSIONS

This new data analysis demonstrates that comparative bioequivalence might be assessed more easily.

摘要

目的

在应用药品后进行角质层胶带剥离,随后分析该组织层中的活性剂,这是一种正在被认真考虑用于局部生物利用度比较评估的方法。关键问题围绕如何以最佳方式进行该实验以及解释数据。

方法

利用先前发表的三项0.025%维甲酸凝胶产品比较研究的结果,提出了替代数据分析方法,这些方法可能使该技术更易于用于评估新的和通用的局部剂型。

结果

对于维甲酸凝胶研究,仅在一个摄取时间和一个清除时间测量药物水平得出的生物等效性结论与原始研究相同,原始研究需要在八个不同治疗时间进行测量。此外,在一个摄取时间和一个清除时间比较药物水平能够区分清除和摄取方面生物等效性的差异,而这些差异在之前被遗漏了。从药物清除的时间进程数据得出的半衰期估计值可能与药物穿透角质层的滞后时间相关。

结论

这种新的数据分析表明,比较生物等效性可能更容易评估。

相似文献

1
Optimizing metrics for the assessment of bioequivalence between topical drug products.优化局部用药品生物等效性评估的指标
Pharm Res. 2008 Jul;25(7):1621-30. doi: 10.1007/s11095-008-9577-4. Epub 2008 May 1.
2
Stratum Corneum Sampling to Assess Bioequivalence between Topical Acyclovir Products.表皮取样评估外用阿昔洛韦产品的生物等效性。
Pharm Res. 2019 Nov 14;36(12):180. doi: 10.1007/s11095-019-2707-3.
3
Assessment of dermatopharmacokinetic approach in the bioequivalence determination of topical tretinoin gel products.皮肤病药代动力学方法在局部用维甲酸凝胶产品生物等效性测定中的应用评估。
J Am Acad Dermatol. 2003 May;48(5):740-51. doi: 10.1067/mjd.2003.175.
4
Bioequivalence Methodologies for Topical Drug Products: In Vitro and Ex Vivo Studies with a Corticosteroid and an Anti-Fungal Drug.局部用药品的生物等效性方法:皮质类固醇和抗真菌药物的体外和离体研究
Pharm Res. 2017 Apr;34(4):730-737. doi: 10.1007/s11095-017-2099-1. Epub 2017 Jan 17.
5
Determining bioequivalence of topical dermatological drug products by tape-stripping.通过胶带剥离法测定局部用皮肤科药品的生物等效性。
J Pharmacokinet Pharmacodyn. 2008 Jun;35(3):337-48. doi: 10.1007/s10928-008-9091-7. Epub 2008 May 9.
6
Application of an Optimized Tape Stripping Method for the Bioequivalence Assessment of Topical Acyclovir Creams.优化的胶带剥离法在评估局部阿昔洛韦乳膏生物等效性中的应用。
AAPS PharmSciTech. 2018 May;19(4):1567-1573. doi: 10.1208/s12249-018-0971-x. Epub 2018 Feb 26.
7
Improved bioequivalence assessment of topical dermatological drug products using dermatopharmacokinetics.利用皮肤药代动力学改进局部皮肤药物产品的生物等效性评估。
Pharm Res. 2009 Feb;26(2):316-28. doi: 10.1007/s11095-008-9742-9. Epub 2008 Oct 22.
8
Topical bioavailability of diclofenac from locally-acting, dermatological formulations.双氯芬酸在局部作用的皮肤科制剂中的局部生物利用度。
Int J Pharm. 2017 Aug 30;529(1-2):55-64. doi: 10.1016/j.ijpharm.2017.06.063. Epub 2017 Jun 19.
9
Bioequivalence of topical clotrimazole formulations: an improved tape stripping method.局部克霉唑制剂的生物等效性:一种改进的胶带剥离法。
J Pharm Pharm Sci. 2011;14(3):347-57. doi: 10.18433/j3rp5k.
10
Assessing the bioequivalence of topical retinoid products by pharmacodynamic assay.通过药效学测定评估局部维 A 酸类产品的生物等效性。
Skin Pharmacol Physiol. 2012;25(5):269-80. doi: 10.1159/000339899. Epub 2012 Jul 27.

引用本文的文献

1
The Implications of Regulatory Framework for Topical Semisolid Drug Products: From Critical Quality and Performance Attributes towards Establishing Bioequivalence.局部用半固体制剂药品监管框架的意义:从关键质量和性能属性到生物等效性的确立
Pharmaceutics. 2021 May 13;13(5):710. doi: 10.3390/pharmaceutics13050710.
2
Novel Approach for the Bioequivalence Assessment of Topical Cream Formulations: Model-Based Analysis of Tape Stripping Data Correctly Concludes BE and BIE.一种评估外用乳膏制剂生物等效性的新方法:基于模型的胶带撕脱数据分析正确得出 BE 和 BIE 结论。
Pharm Res. 2020 Jan 2;37(2):20. doi: 10.1007/s11095-019-2724-2.
3

本文引用的文献

1
Assessment of dermatopharmacokinetic approach in the bioequivalence determination of topical tretinoin gel products.皮肤病药代动力学方法在局部用维甲酸凝胶产品生物等效性测定中的应用评估。
J Am Acad Dermatol. 2003 May;48(5):740-51. doi: 10.1067/mjd.2003.175.
2
Determining dermal absorption parameters in vivo from tape strip data.从胶带剥离数据体内确定皮肤吸收参数。
Pharm Res. 2002 Mar;19(3):292-8. doi: 10.1023/a:1014443001802.
3
Comparison of dermatopharmacokinetic vs. clinicial efficacy methods for bioequivalence assessment of miconazole nitrate vaginal cream, 2% in humans.
Bioequivalence Methodologies for Topical Drug Products: In Vitro and Ex Vivo Studies with a Corticosteroid and an Anti-Fungal Drug.
局部用药品的生物等效性方法:皮质类固醇和抗真菌药物的体外和离体研究
Pharm Res. 2017 Apr;34(4):730-737. doi: 10.1007/s11095-017-2099-1. Epub 2017 Jan 17.
4
Pharmacokinetics-Based Approaches for Bioequivalence Evaluation of Topical Dermatological Drug Products.基于药代动力学的局部皮肤药品生物等效性评价方法
Clin Pharmacokinet. 2015 Nov;54(11):1095-106. doi: 10.1007/s40262-015-0292-0.
5
Bioequivalence for topical products--an update.局部用制剂的生物等效性——更新。
Pharm Res. 2010 Dec;27(12):2590-601. doi: 10.1007/s11095-010-0250-3. Epub 2010 Sep 22.
6
Rapid sampling of molecules via skin for diagnostic and forensic applications.通过皮肤快速采集分子,用于诊断和法医应用。
Pharm Res. 2010 Jul;27(7):1255-63. doi: 10.1007/s11095-010-0081-2. Epub 2010 Mar 18.
7
Dermatopharmacokinetics: factors influencing drug clearance from the stratum corneum.皮肤药代动力学:影响药物从角质层清除的因素。
Pharm Res. 2009 Apr;26(4):865-71. doi: 10.1007/s11095-008-9785-y. Epub 2008 Nov 25.
8
Improved bioequivalence assessment of topical dermatological drug products using dermatopharmacokinetics.利用皮肤药代动力学改进局部皮肤药物产品的生物等效性评估。
Pharm Res. 2009 Feb;26(2):316-28. doi: 10.1007/s11095-008-9742-9. Epub 2008 Oct 22.
2%硝酸咪康唑阴道乳膏在人体中的生物等效性评估:皮肤药代动力学与临床疗效方法的比较
Pharm Res. 2002 Mar;19(3):270-7. doi: 10.1023/a:1014486716823.
4
Assessment and prediction of the cutaneous bioavailability of topical terbinafine, in vivo, in man.体内人体外用特比萘芬皮肤生物利用度的评估与预测
Pharm Res. 2001 Oct;18(10):1472-5. doi: 10.1023/a:1012217209228.
5
Skin, the final frontier.皮肤,最后的前沿领域。
Int J Pharm. 2001 Aug 14;224(1-2):1-18. doi: 10.1016/s0378-5173(01)00731-1.
6
Effect of ethanol and isopropyl myristate on the availability of topical terbinafine in human stratum corneum, in vivo.乙醇和肉豆蔻酸异丙酯对人角质层中局部用特比萘芬体内可用性的影响。
Int J Pharm. 2001 May 21;219(1-2):11-9. doi: 10.1016/s0378-5173(01)00616-0.
7
In vivo assessment of enhanced topical delivery of terbinafine to human stratum corneum.特比萘芬经皮给药至人角质层的体内增强递送评估。
J Control Release. 2001 Apr 28;71(3):319-27. doi: 10.1016/s0168-3659(01)00244-9.
8
Bioequivalence of topical dermatological dosage forms--methods of evaluation of bioequivalence.局部皮肤剂型的生物等效性——生物等效性评估方法
Pharm Res. 1998 Feb;15(2):167-71. doi: 10.1023/a:1011941929495.
9
Characterization of the permeability barrier of human skin in vivo.人体皮肤体内渗透屏障的特性研究
Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1562-7. doi: 10.1073/pnas.94.4.1562.
10
A new method for estimating dermal absorption from chemical exposure. 1. General approach.一种估算化学物质暴露引起的皮肤吸收的新方法。1. 一般方法。
Pharm Res. 1993 Apr;10(4):497-506. doi: 10.1023/a:1018981515480.